Aditi Pharmaceuticals Pvt Ltd, a active private limited company, was established on 07 May 1985 in Solapur, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239PN1985PTC036140. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.12 Cr.
It upholds a compliant status. Employing 103 professional, Its leadership includes Jemini Atul Bakshi (Director), Atul Shantilal Bakshi (Managing Director). Past directors included Kruti Atul Bakshi, Shantilal Sakarlal Bakshi, Rajeev Walchand Karkamkar. It holds no open charges and ₹1.17 Cr settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at E/65/66 Midc Akkalkot Road, Solapur, Maharashtra, 413006.
U24239PN1985PTC036140
036140
07 May 1985
₹1.50 Cr
₹1.12 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Aditi Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jemini Atul Bakshi | Director | 03 Oct 2007 | Current |
| Atul Shantilal Bakshi | Managing Director | 07 May 1985 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jun 2011 | Past |
| Pramod Abcsdd | Director | 15 Dec 2011 | Past |
| Pramod Abcsdd | Director | 30 Aug 2019 | Past |
| Pramod Abcsdd | Director | 20 Jun 2020 | Past |
| Pramod Abcsdd | Additional Director | 22 Aug 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aditi Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 39.26% increase. The company also saw a substantial improvement in profitability, with a 204.59% increase in profit. The company's net worth Soared by an impressive increase of 11.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Aditi Pharmaceuticals had a public holding of 11.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹11,650,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2000 | Maharashtra State Financial Corporation | ₹3.15 M | Satisfied |
| 31 Mar 1995 | Maharashtra State Financial Corporation | ₹2.00 M | Satisfied |
| 04 Jul 1994 | Maharashtra State Financial Corporation | ₹3.00 M | Satisfied |
| 09 Sep 1993 | State Bank Of India | ₹0.50 M | Satisfied |
| 04 Jul 1986 | Maharashtra State Financial Corporation | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Aditi Pharmaceuticals has a workforce of 103 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aditi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aditi Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aditi Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was recorded as a recent event.
Progress on Aditi Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
The activity A charge registered on 01 Nov 2000 via Charge ID 90082680 with Maharashtra State Financial Corporation was fully satisfied on 20 Jan 2015. was completed.
Progress on A charge registered on 31 Mar 1995 via Charge ID 90082424 with Maharashtra State Financial Corporation was fully satisfied on 20 Jan 2015. was documented.
A charge registered on 04 Jul 1994 via Charge ID 90093620 with Maharashtra State Financial Corporation was fully satisfied on 20 Jan 2015. was recorded as a recent event.
Progress on A charge registered on 04 Jul 1986 via Charge ID 90093524 with Maharashtra State Financial Corporation was fully satisfied on 20 Jan 2015. was documented.
The CIN of Aditi Pharmaceuticals Pvt Ltd is U24239PN1985PTC036140.
Aditi Pharmaceuticals Pvt Ltd is headquartered at E/65/66 Midc Akkalkot Road, Solapur, Maharashtra, 413006.
Aditi Pharmaceuticals Pvt Ltd was incorporated on 07 May 1985.
The current directors of Aditi Pharmaceuticals Pvt Ltd are
The primary industry of Aditi Pharmaceuticals Pvt Ltd is Manufacturing.
Aditi Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Aditi Pharmaceuticals Pvt Ltd is ₹1.50 Cr, and the paid-up capital is ₹1.12 Cr.
The compliance status of Aditi Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX